Although FOXA2 was regarded to suppress EMT during pancreatic ductal adenocarcinoma malignant progression [45], genomic analyses depicted that pancreatic progenitor tumors preferentially express genes involved in early pancreatic development (FOXA2) [46]. This evidence concerns the gene FOXA2 and pancreatic ductal adenocarcinoma.